Concord Healthcare Grp Co (2453.HK) Q3 2024 Earnings Report

Revenue: 84,658,500; YoY change: -33.02%; QoQ change: -22.65%; Gross Profit: -16,373,000; Gross Margin: -19.34%; EBITDA: -50,184,500; EBITDA Margin: -0.59; Operating Income: -108,080,000; Operating Margin: -1.28%; Net Income: -130,673,499; Net Margin: -1.54%; EPS: -0.18; Weighted Avg Shares: 716.31 million. Cash flow metrics show Net Cash from Operating Activities of -3.58 million and Capital Expenditures of 84.02 million, with investing activities (-101.87 million) and financing activities (+151.96 million) contributing to an estimated net cash inflow of roughly 46.5 million for the period. Balance sheet highlights include Total Assets of 5.906 billion and Total Liabilities of 4.006 billion, with Total Equity of 1.648 billion. Liquidity remains tight (Current Ratio 0.63, Quick Ratio 0.60, Cash Ratio 0.18) despite a positive net cash flow from financing activities.